| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Sitagliptin Phosphate | FAERS: 2 | US FAERS | |
| 2 | Interferon alpha-2 | FAERS: 1 | US FAERS | |
| 3 | Linagliptin | FAERS: 1 | US FAERS | |
| 4 | Liraglutide | FAERS: 1 | US FAERS | |
| 5 | Loperamide | FAERS: 1 | US FAERS | |
| 6 | Sorafenib | FAERS: 1 | US FAERS | |
| 7 | Tigecycline | FAERS: 1 | US FAERS | |
| 8 | Valproic Acid | FAERS: 1 | US FAERS | |
| 9 | carbidopa, levodopa drug combination | FAERS: 1 | US FAERS | |
| 10 | pirfenidone | FAERS: 1 | US FAERS | |
| 11 | pitavastatin | FAERS: 1 | US FAERS | |
| 12 | candesartan cilexetil | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120326
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.